Dr. Ivón Peña, a clinical nutritionist and Medical Director at Control Clinic, stated that GLP-1 medications are natural hormones produced by the body that act as messengers between the intestine, brain, and pancreas. ^[1] RonanRx, a Y Combinator-backed telehealt startup, announced on its website that it offers personalized GLP-1 care in which a licensed physician reviews each patient's history to set a starting dose and titration schedule, rather than a one-size-fits-all label. ^[2] Dr. Ivón Peña noted that GLP-1 therapy aims to reduce health risks such as hypertension, fatty liver, sleep apnea, and major cardiovascular events. ^[3] Dr. Ivón Peña stated that prescribing GLP-1 medications requires a rigorous medical exercise involving a comprehensive review of clinical history, laboratory profiles, and contraindications. ^[4] Dr. Ivón Peña warned that the common error is reducing the use of GLP-1 medications to rapid weight loss driven by social trends rather than medical necessity. ^[5] RonanRx asserts that cash-pay list prices for brand-name GLP-1s cause people to ration doses or quit, and that compounded patient-specific preparations can cost less, though actual cost depends on the prescriber's plan, selected pharmacy, and state. ^[6] RonanRx states that a doctor-led authority chain governs each prescription: a licensed physician writes the patient-specific prescription, and a licensed pharmacist at the patient's selected pharmacy verifies and releases only what the prescriber orders. ^[7] RonanRx says its personalization may include a patient-specific adjunct such as B12 or anti-nausea support when it helps tolerability or consistency. ^[8]